During the past decade, Henry Ford Health System conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Henry Ford Health System" are "Cancer" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials), "Neoplasms" (1 trials) and "Nonarteritic Anterior Ischemic Optic Neuropathy" (1 trials). Many other conditions were trialed in "Henry Ford Health System" in a lesser frequency.

Most popular intervention types in "Henry Ford Health System" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "GLPG1690" (1 trials), "PDE5 Inhibitors" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Health System" are 1 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Henry Ford Health System". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Henry Ford Health System, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Health System, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".